Cargando…
Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients
Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca(2+)) mishandling. Ca(2+) release from the sarcoplasmic...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657486/ https://www.ncbi.nlm.nih.gov/pubmed/34884796 http://dx.doi.org/10.3390/ijms222312985 |
_version_ | 1784612514853552128 |
---|---|
author | Meyer, Pierre Notarnicola, Cécile Meli, Albano C. Matecki, Stefan Hugon, Gérald Salvador, Jérémy Khalil, Mirna Féasson, Léonard Cances, Claude Cottalorda, Jérôme Desguerre, Isabelle Cuisset, Jean-Marie Sabouraud, Pascal Lacampagne, Alain Chevassus, Hugues Rivier, François Carnac, Gilles |
author_facet | Meyer, Pierre Notarnicola, Cécile Meli, Albano C. Matecki, Stefan Hugon, Gérald Salvador, Jérémy Khalil, Mirna Féasson, Léonard Cances, Claude Cottalorda, Jérôme Desguerre, Isabelle Cuisset, Jean-Marie Sabouraud, Pascal Lacampagne, Alain Chevassus, Hugues Rivier, François Carnac, Gilles |
author_sort | Meyer, Pierre |
collection | PubMed |
description | Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca(2+)) mishandling. Ca(2+) release from the sarcoplasmic reticulum is mostly mediated by the type 1 ryanodine receptor (RYR1) that is required for skeletal muscle differentiation in animals. The study objective was to determine whether altered RYR1-mediated Ca(2+) release contributes to myogenic differentiation impairment in DMD patients. The comparison of primary cultured myoblasts from six boys with DMD and five healthy controls highlighted delayed myoblast differentiation in DMD. Silencing RYR1 expression using specific si-RNA in a healthy control induced a similar delayed differentiation. In DMD myotubes, resting intracellular Ca(2+) concentration was increased, but RYR1-mediated Ca(2+) release was not changed compared with control myotubes. Incubation with the RYR-calstabin interaction stabilizer S107 decreased resting Ca(2+) concentration in DMD myotubes to control values and improved calstabin1 binding to the RYR1 complex. S107 also improved myogenic differentiation in DMD. Furthermore, intracellular Ca(2+) concentration was correlated with endomysial fibrosis, which is the only myopathologic parameter associated with poor motor outcome in patients with DMD. This suggested a potential relationship between RYR1 dysfunction and motor impairment. Our study highlights RYR1-mediated Ca(2+) leakage in human DMD myotubes and its key role in myogenic differentiation impairment. RYR1 stabilization may be an interesting adjunctive therapeutic strategy in DMD. |
format | Online Article Text |
id | pubmed-8657486 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86574862021-12-10 Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients Meyer, Pierre Notarnicola, Cécile Meli, Albano C. Matecki, Stefan Hugon, Gérald Salvador, Jérémy Khalil, Mirna Féasson, Léonard Cances, Claude Cottalorda, Jérôme Desguerre, Isabelle Cuisset, Jean-Marie Sabouraud, Pascal Lacampagne, Alain Chevassus, Hugues Rivier, François Carnac, Gilles Int J Mol Sci Article Duchenne muscular dystrophy (DMD) is characterized by progressive muscle wasting following repeated muscle damage and inadequate regeneration. Impaired myogenesis and differentiation play a major role in DMD as well as intracellular calcium (Ca(2+)) mishandling. Ca(2+) release from the sarcoplasmic reticulum is mostly mediated by the type 1 ryanodine receptor (RYR1) that is required for skeletal muscle differentiation in animals. The study objective was to determine whether altered RYR1-mediated Ca(2+) release contributes to myogenic differentiation impairment in DMD patients. The comparison of primary cultured myoblasts from six boys with DMD and five healthy controls highlighted delayed myoblast differentiation in DMD. Silencing RYR1 expression using specific si-RNA in a healthy control induced a similar delayed differentiation. In DMD myotubes, resting intracellular Ca(2+) concentration was increased, but RYR1-mediated Ca(2+) release was not changed compared with control myotubes. Incubation with the RYR-calstabin interaction stabilizer S107 decreased resting Ca(2+) concentration in DMD myotubes to control values and improved calstabin1 binding to the RYR1 complex. S107 also improved myogenic differentiation in DMD. Furthermore, intracellular Ca(2+) concentration was correlated with endomysial fibrosis, which is the only myopathologic parameter associated with poor motor outcome in patients with DMD. This suggested a potential relationship between RYR1 dysfunction and motor impairment. Our study highlights RYR1-mediated Ca(2+) leakage in human DMD myotubes and its key role in myogenic differentiation impairment. RYR1 stabilization may be an interesting adjunctive therapeutic strategy in DMD. MDPI 2021-11-30 /pmc/articles/PMC8657486/ /pubmed/34884796 http://dx.doi.org/10.3390/ijms222312985 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Meyer, Pierre Notarnicola, Cécile Meli, Albano C. Matecki, Stefan Hugon, Gérald Salvador, Jérémy Khalil, Mirna Féasson, Léonard Cances, Claude Cottalorda, Jérôme Desguerre, Isabelle Cuisset, Jean-Marie Sabouraud, Pascal Lacampagne, Alain Chevassus, Hugues Rivier, François Carnac, Gilles Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients |
title | Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients |
title_full | Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients |
title_fullStr | Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients |
title_full_unstemmed | Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients |
title_short | Skeletal Ryanodine Receptors Are Involved in Impaired Myogenic Differentiation in Duchenne Muscular Dystrophy Patients |
title_sort | skeletal ryanodine receptors are involved in impaired myogenic differentiation in duchenne muscular dystrophy patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8657486/ https://www.ncbi.nlm.nih.gov/pubmed/34884796 http://dx.doi.org/10.3390/ijms222312985 |
work_keys_str_mv | AT meyerpierre skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT notarnicolacecile skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT melialbanoc skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT mateckistefan skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT hugongerald skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT salvadorjeremy skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT khalilmirna skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT feassonleonard skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT cancesclaude skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT cottalordajerome skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT desguerreisabelle skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT cuissetjeanmarie skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT sabouraudpascal skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT lacampagnealain skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT chevassushugues skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT rivierfrancois skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients AT carnacgilles skeletalryanodinereceptorsareinvolvedinimpairedmyogenicdifferentiationinduchennemusculardystrophypatients |